文献速递肿瘤 PET/CT

儿童淋巴瘤影像学检查:不同18F-FDG PET/MRI协议与全身弥散加权MRI的比较评估

Imaging children suffering from lymphoma: an evaluation of different 18F-FDG PET/MRI protocols compared to whole-body DW-MRI.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-05-22

该研究纳入28例儿童淋巴瘤患者的18F-FDG PET/MRI数据集,比较四种阅片协议(单纯平扫、增强、平扫+增强+弥散加权、全身弥散加权MRI)的病灶检测与分期能力。PET/MRI识别全部17例活动性淋巴瘤,全身弥散加权MRI识别15/17例;是否使用对比剂或弥散加权成像并未明显提高PET/MRI的诊断准确性。

要点

  • PET/MRI识别全部17例活动性淋巴瘤,全身弥散加权MRI识别15/17例。
  • PET/MRI诊断准确性为96%–97%,全身弥散加权MRI为86%。
  • 加入对比剂或弥散加权成像未明显提高PET/MRI诊断准确性。

核心结论

  • 18F-FDG PET/MRI在儿童淋巴瘤分期方面优于全身弥散加权MRI。
  • 是否使用对比剂或弥散加权成像并未明显提高PET/MRI的诊断准确性。
  • 作者认为,平扫PET/MRI未来可能在儿童淋巴瘤的诊断评估中发挥重要作用。

研究设计与样本

  • 共纳入28例18F-FDG PET/MRI数据集,分析四种阅片协议。
  • 四种协议分别为:单纯平扫T2w和T1w的PET/MRI、增加增强序列的PET/MRI、平扫联合增强及弥散加权成像的PET/MRI、全身弥散加权MRI。
  • 以随访、既往检查及组织病理学作为参考标准,按患者和按病灶进行分析。

主要发现

  • PET/MRI正确识别全部17例活动性淋巴瘤检查,全身弥散加权MRI正确识别15/17例。
  • 协议1的敏感度、特异度、阳性预测值、阴性预测值、诊断准确性分别为96%、96.5%、97%、95%、96%。
  • 协议2和协议3的敏感度、特异度、阳性预测值、阴性预测值、诊断准确性分别为97%、96.5%、97%、96.5%、97%。
  • 全身弥散加权MRI的敏感度、特异度、阳性预测值、阴性预测值、诊断准确性分别为77%、96%、96%、78.5%、86%。

关键数值与推荐

  • 协议1(单纯平扫T2w和T1w的PET/MRI):诊断准确性96%。
  • 协议2(增加增强序列的PET/MRI):诊断准确性97%。
  • 协议3(平扫联合增强及弥散加权成像的PET/MRI):诊断准确性97%。
  • 全身弥散加权MRI:诊断准确性86%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The objectives of this study were to evaluate and compare the diagnostic potential of different PET/MRI reading protocols, entailing non-enhanced / contrast-enhanced and diffusion-weighted 18F-FDG PET/MR imaging and whole-body diffusion-weighted MRI for lesion detection and determination of the tumor stage in pediatric lymphoma patients. METHODS: A total of 28 18F-FDG PET/MRI datasets were included for analysis of four different reading protocols: (1) PET/MRI utilizing sole unenhanced T2w and T1w imaging, (2) PET/MRI utilizing additional contrast enhanced sequences, (3) PET/MR imaging utilizing unenhanced, contrast enhanced and DW imaging or (4) WB-DW-MRI. Statistical analyses were performed on a per-patient and a per-lesion basis. Follow-up and prior examinations as well as histopathology served as reference standards. RESULTS: PET/MRI correctly identified all 17 examinations with active lymphoma disease, while WB-DW-MRI correctly identified 15/17 examinations. Sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy were 96%, 96.5%, 97%, 95%, and 96% for PET/MRI1; 97%, 96.5%, 97%, 96.5%, and 97% for PET/MRI2; 97%, 96.5%, 97%, 96.5%, and 97% for PET/MRI3 and 77%, 96%, 96%, 78.5% and 86% for MRI-DWI. CONCLUSION: 18F-FDG PET/MRI is superior to WB-DW-MRI in staging pediatric lymphoma patients. Neither application of contrast media nor DWI leads to a noticeable improvement of the diagnostic accuracy of PET/MRI. Thus, unenhanced PET/MRI may play a crucial role for the diagnostic work-up of pediatric lymphoma patients in the future.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Kirchner J, Deuschl C, Schweiger B, et al. Imaging children suffering from lymphoma: an evaluation of different 18F-FDG PET/MRI protocols compared to whole-body DW-MRI. Eur J Nucl Med Mol Imaging. 2017. PMID: 28534182. doi:10.1007/s00259-017-3726-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。